# Ispire Technology Inc.: financial statements, quarterly

ISPR · Nasdaq · CIK 1948455 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/ispr.md) · [Financials](/companies/ispr/financials.md) · [Filings](/companies/ispr/filings.md) · [Insiders](/companies/ispr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ispr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [42.9](/filings/0001213900-24-096805.md) | [41.7](/filings/0001213900-25-011336.md) | [30.0](/filings/0001213900-25-041555.md) | [37.3 d](/filings/0001213900-25-087632.md) | [39.3](/filings/0001213900-25-107205.md) | [41.8](/filings/0001213900-26-013305.md) | [26.2](/filings/0001213900-26-053368.md) | [20.1 d](/filings/0001213900-26-100146.md) | [30.4](/filings/0001213900-25-107205.md) | [20.3](/filings/0001213900-26-013305.md) | [18.7](/filings/0001213900-26-053368.md) | [26.7 d](/filings/0001213900-26-100146.md) |
| Cost of revenue | $m | [36.0](/filings/0001213900-24-096805.md) | [35.4](/filings/0001213900-25-011336.md) | [23.9](/filings/0001213900-25-041555.md) | [26.8 d](/filings/0001213900-25-087632.md) | [31.7](/filings/0001213900-25-107205.md) | [34.1](/filings/0001213900-26-013305.md) | [21.4](/filings/0001213900-26-053368.md) | [17.7 d](/filings/0001213900-26-100146.md) | [25.2](/filings/0001213900-25-107205.md) | [16.8](/filings/0001213900-26-013305.md) | [16.7](/filings/0001213900-26-053368.md) | [25.0 d](/filings/0001213900-26-100146.md) |
| Gross profit | $m | [6.8](/filings/0001213900-24-096805.md) | [6.3](/filings/0001213900-25-011336.md) | [6.1](/filings/0001213900-25-041555.md) | [10.6 d](/filings/0001213900-25-087632.md) | [7.7](/filings/0001213900-25-107205.md) | [7.7](/filings/0001213900-26-013305.md) | [4.8](/filings/0001213900-26-053368.md) | [2.5 d](/filings/0001213900-26-100146.md) | [5.1](/filings/0001213900-25-107205.md) | [3.5](/filings/0001213900-26-013305.md) | [2.0](/filings/0001213900-26-053368.md) | [1.7 d](/filings/0001213900-26-100146.md) |
| Research and development | $m | not reported | [0.0](/filings/0001213900-24-015395.md) | [0.2](/filings/0001213900-24-042990.md) | [(0.0) d](/filings/0001213900-25-087632.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(0.9)](/filings/0001213900-24-096805.md) | [(3.9)](/filings/0001213900-25-011336.md) | [(5.7)](/filings/0001213900-25-041555.md) | [(3.4) d](/filings/0001213900-25-087632.md) | [(5.3)](/filings/0001213900-25-107205.md) | [(7.4)](/filings/0001213900-26-013305.md) | [(10.6)](/filings/0001213900-26-053368.md) | [(14.6) d](/filings/0001213900-26-100146.md) | [(2.7)](/filings/0001213900-25-107205.md) | [(6.9)](/filings/0001213900-26-013305.md) | [(9.5)](/filings/0001213900-26-053368.md) | [(13.5) d](/filings/0001213900-26-100146.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-25-107205.md) | [0.0](/filings/0001213900-26-013305.md) | [0.0](/filings/0001213900-26-053368.md) | [0.1 d](/filings/0001213900-26-100146.md) | [0.1](/filings/0001213900-25-107205.md) | [0.1](/filings/0001213900-26-013305.md) | [0.1](/filings/0001213900-26-053368.md) | [0.1 d](/filings/0001213900-26-100146.md) |
| Income tax | $m | [0.5](/filings/0001213900-24-096805.md) | [0.4](/filings/0001213900-25-011336.md) | [0.3](/filings/0001213900-25-041555.md) | [0.2 d](/filings/0001213900-25-087632.md) | [0.5](/filings/0001213900-25-107205.md) | [0.5](/filings/0001213900-26-013305.md) | [0.2](/filings/0001213900-26-053368.md) | [0.1 d](/filings/0001213900-26-100146.md) | [0.5](/filings/0001213900-25-107205.md) | [0.1](/filings/0001213900-26-013305.md) | [0.2](/filings/0001213900-26-053368.md) | [0.4 d](/filings/0001213900-26-100146.md) |
| Net income | $m | [(1.3)](/filings/0001213900-24-096805.md) | [(4.0)](/filings/0001213900-25-011336.md) | [(5.9)](/filings/0001213900-25-041555.md) | [(3.5) d](/filings/0001213900-25-087632.md) | [(5.6)](/filings/0001213900-25-107205.md) | [(8.0)](/filings/0001213900-26-013305.md) | [(10.9)](/filings/0001213900-26-053368.md) | [(14.8) d](/filings/0001213900-26-100146.md) | [(3.3)](/filings/0001213900-25-107205.md) | [(6.6)](/filings/0001213900-26-013305.md) | [(9.5)](/filings/0001213900-26-053368.md) | [(13.8) d](/filings/0001213900-26-100146.md) |
| Diluted EPS | $ per share | [(0.02)](/filings/0001213900-24-096805.md) | [(0.07)](/filings/0001213900-25-011336.md) | [(0.11)](/filings/0001213900-25-041555.md) | not reported | [(0.10)](/filings/0001213900-25-107205.md) | [(0.14)](/filings/0001213900-26-013305.md) | [(0.19)](/filings/0001213900-26-053368.md) | not reported | [(0.06)](/filings/0001213900-25-107205.md) | [(0.12)](/filings/0001213900-26-013305.md) | [(0.17)](/filings/0001213900-26-053368.md) | not reported |
| Basic EPS | $ per share | [(0.02)](/filings/0001213900-24-096805.md) | [(0.07)](/filings/0001213900-25-011336.md) | [(0.11)](/filings/0001213900-25-041555.md) | not reported | [(0.10)](/filings/0001213900-25-107205.md) | [(0.14)](/filings/0001213900-26-013305.md) | [(0.19)](/filings/0001213900-26-053368.md) | not reported | [(0.06)](/filings/0001213900-25-107205.md) | [(0.12)](/filings/0001213900-26-013305.md) | [(0.17)](/filings/0001213900-26-053368.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.7](/filings/0001213900-24-096805.md) | [17.5](/filings/0001213900-25-011336.md) | [39.5](/filings/0001213900-25-041555.md) | [35.1](/filings/0001213900-25-087632.md) | [37.7](/filings/0001213900-25-107205.md) | [34.4](/filings/0001213900-26-013305.md) | [23.5](/filings/0001213900-26-053368.md) | [24.4](/filings/0001213900-26-100146.md) | [22.7](/filings/0001213900-25-107205.md) | [17.6](/filings/0001213900-26-013305.md) | [18.0](/filings/0001213900-26-053368.md) | [19.3](/filings/0001213900-26-100146.md) |
| Current assets | $m | [81.6](/filings/0001213900-23-086406.md) | [83.0](/filings/0001213900-24-015395.md) | [98.7](/filings/0001213900-24-042990.md) | [103](/filings/0001213900-25-087632.md) | [109](/filings/0001213900-24-096805.md) | [112](/filings/0001213900-25-011336.md) | [94.0](/filings/0001213900-25-041555.md) | [72.9](/filings/0001213900-26-100146.md) | [75.1](/filings/0001213900-25-107205.md) | [63.7](/filings/0001213900-26-013305.md) | [55.7](/filings/0001213900-26-053368.md) | [45.4](/filings/0001213900-26-100146.md) |
| Total assets | $m | [88.1](/filings/0001213900-24-082378.md) | [90.4](/filings/0001213900-24-082378.md) | [108](/filings/0001213900-24-082378.md) | [123](/filings/0001213900-25-087632.md) | [129](/filings/0001213900-24-096805.md) | [132](/filings/0001213900-25-011336.md) | [116](/filings/0001213900-25-041555.md) | [102](/filings/0001213900-26-100146.md) | [96.4](/filings/0001213900-25-107205.md) | [84.4](/filings/0001213900-26-013305.md) | [75.9](/filings/0001213900-26-053368.md) | [64.3](/filings/0001213900-26-100146.md) |
| Current liabilities | $m | [53.9](/filings/0001213900-24-082378.md) | [58.4](/filings/0001213900-24-082378.md) | [69.6](/filings/0001213900-24-082378.md) | [86.0](/filings/0001213900-25-087632.md) | [96.4](/filings/0001213900-24-096805.md) | [106](/filings/0001213900-25-011336.md) | [96.2](/filings/0001213900-25-041555.md) | [72.5](/filings/0001213900-26-100146.md) | [65.8](/filings/0001213900-25-107205.md) | [60.2](/filings/0001213900-26-013305.md) | [54.9](/filings/0001213900-26-053368.md) | [44.6](/filings/0001213900-26-100146.md) |
| Total liabilities | $m | [57.0](/filings/0001213900-24-082378.md) | [61.2](/filings/0001213900-24-082378.md) | [72.1](/filings/0001213900-24-082378.md) | [88.2](/filings/0001213900-25-087632.md) | [98.2](/filings/0001213900-24-096805.md) | [108](/filings/0001213900-25-011336.md) | [101](/filings/0001213900-25-041555.md) | [102](/filings/0001213900-26-100146.md) | [98.2](/filings/0001213900-25-107205.md) | [92.1](/filings/0001213900-26-013305.md) | [92.1](/filings/0001213900-26-053368.md) | [93.5](/filings/0001213900-26-100146.md) |
| Shareholders' equity | $m | [31.1](/filings/0001213900-25-011336.md) | [29.1](/filings/0001213900-25-041555.md) | [35.9](/filings/0001213900-25-041555.md) | [34.5](/filings/0001213900-26-100146.md) | [30.7](/filings/0001213900-26-013305.md) | [24.2](/filings/0001213900-26-053368.md) | [14.8](/filings/0001213900-26-053368.md) | [0.6](/filings/0001213900-26-100146.md) | [(1.8)](/filings/0001213900-26-013305.md) | [(7.7)](/filings/0001213900-26-053368.md) | [(16.2)](/filings/0001213900-26-053368.md) | [(29.2)](/filings/0001213900-26-100146.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(13.1)](/filings/0001213900-24-096805.md) | [(7.1) d](/filings/0001213900-25-011336.md) | [3.4 d](/filings/0001213900-25-041555.md) | [(1.4) d](/filings/0001213900-25-087632.md) | [3.6](/filings/0001213900-25-107205.md) | [(3.2) d](/filings/0001213900-26-013305.md) | [(12.5) d](/filings/0001213900-26-053368.md) | [4.7 d](/filings/0001213900-26-100146.md) | [(1.2)](/filings/0001213900-25-107205.md) | [(4.0) d](/filings/0001213900-26-013305.md) | [2.0 d](/filings/0001213900-26-053368.md) | [2.6 d](/filings/0001213900-26-100146.md) |
| Capital expenditure | $m | [0.5](/filings/0001213900-24-096805.md) | [0.6 d](/filings/0001213900-25-011336.md) | [0.1 d](/filings/0001213900-25-041555.md) | [0.8 d](/filings/0001213900-25-087632.md) | [0.3](/filings/0001213900-25-107205.md) | [0.1 d](/filings/0001213900-26-013305.md) | [(0.2) d](/filings/0001213900-26-053368.md) | [1.0 d](/filings/0001213900-26-100146.md) | [0.0](/filings/0001213900-25-107205.md) | [0.1 d](/filings/0001213900-26-013305.md) | [0.2 d](/filings/0001213900-26-053368.md) | [(0.0) d](/filings/0001213900-26-100146.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001213900-26-100146.md) | not reported | not reported | [0.0 d](/filings/0001213900-26-053368.md) | [0.0 d](/filings/0001213900-26-100146.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2022-09-30) | period not labelled (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [50.0](/filings/0001213900-23-086406.md) | [50.0](/filings/0001213900-24-015395.md) | [50.0](/filings/0001213900-24-042990.md) | [54.2](/filings/0001213900-24-096805.md) | [54.3](/filings/0001213900-25-011336.md) | [54.3](/filings/0001213900-25-041555.md) | [56.6](/filings/0001213900-25-107205.md) | [56.7](/filings/0001213900-26-013305.md) | [57.0](/filings/0001213900-26-053368.md) | [57.3](/filings/0001213900-25-107205.md) | [57.3](/filings/0001213900-26-013305.md) | [57.3](/filings/0001213900-26-053368.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 57,754,471 at 2026-09-14, from the cover of the [10-K filed 2026-09-15](/filings/0001213900-26-100146.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.